The role of adiponectin in renal physiology and development of albuminuria.
Adiponectin is secreted by the adipose tissue and is downregulated in states of obesity and insulin resistance. There is a growing body of evidence indicating that adiponectin has renoprotective effects and protects against the development of albuminuria in rodent experiments. Adiponectin crossing the glomerular filtration barrier possibly inhibits inflammation, fibrosis and oxidative stress in kidneys through activation of AMP-activated protein kinase. Moreover, microalbuminuria is a well established early sign of progressive cardiovascular and renal disease, even in subjects with preserved glomerular filtration rate. Studies investigating the relationship between serum adiponectin levels and urinary albumin excretion rate (UAE) have yielded conflicting data and the mechanisms underlying the interplay between adiponectin and albuminuria remain to be elucidated. This article constitutes a critical review attempting to clarify any remaining confusion about this matter. Furthermore, this article examines the clinical significance of adiponectin-albuminuria interplay, suggesting that adiponectin is possibly involved in the development of albuminuria that is associated with obesity, diabetes and cardiovascular disease and may mediate, at least in part, the actions of medical treatments that influence UAE, such as angiotensin-converting-enzyme inhibitors, angiotensin II receptor blockers, thiazolidinediones, fenofibrate and diet. Further studies to investigate more thoroughly the renoprotective role of adiponectin in the human setting should be carefully planned, focusing on causality and the possible influence of adiponectin on the development of albuminuria in specific clinical settings.
Laboratory of Physiology, Medical School, University of Ioannina, 45110 Ioannina, Greece.
Georgios A
GA
Christou
Dimitrios N
DN
Kiortsis
D052242:Adiponectin / Q000502:physiology*; D000419:Albuminuria / Q000097:blood / Q000378:metabolism* / Q000652:urine; D000818:Animals; D005919:Glomerular Filtration Rate; D006801:Humans; D007668:Kidney / Q000502:physiology*; D009765:Obesity / Q000097:blood / Q000652:urine; D054419:Receptors, Adiponectin / Q000378:metabolism
D052242:Adiponectin; D054419:Receptors, Adiponectin
adipose tissue; cardiovascular disease; diabetic nephropathy; dietary intervention; drug mechanism; fibrates